Keywords: tokai, pharma, closes, 22m, funding, pharmaceuticals, biotechnology

Tokai Pharma closes $22M funding

Article | 12 May 2009

Print This

Tokai Pharmaceuticals, a biotechnology company that is developing a novel therapy for the treatment of advanced prostate cancer, says it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in